Signature

For nearly a quarter of a century, AbbVie has been dedicated to advancing care for people living with rheumatic diseases and is a long-standing partner with the Arthritis Foundation. AbbVie partners with the Arthritis Foundation on many patient educational resources and programs, such as the JA Family Summit, in an effort to improve life for patients and their families. AbbVie has also received the Arthritis Foundation’s Ease of Use Commendation for their prescription medications approved across various rheumatic diseases. To learn more about AbbVie and their commitment to rheumatology, please click here.

Amgen’s partnership with the Arthritis Foundation has spanned nearly two decades. Amgen’s annual partnership and investment in our mission focuses in several areas including patient resources in gout and other arthritic diseases, diversity and health equity work, and advocacy efforts. Amgen has also received the Arthritis Foundation’s Ease of Use seal for their prescription medical device. To learn more about Amgen, please visit https://www.amgen.com. 


Bristol Myers Squibb (BMS) is proud to be a long-time supporter of the Arthritis Foundation and is committed to supporting the arthritis community through education and empowerment. BMS supports the Arthritis Foundation’s local and national programs for patients and their families, including diversity and health equity work, advocacy efforts, and the inflammatory arthritis program. To learn more about BMS, visit www.bms.com. 


Janssen (Johnson & Johnson Innovative Medicine) has been a long-standing partner of the Arthritis Foundation. Janssen is a member of our Arthritis Healthcare Forum and supports the Arthritis Foundation’s advocacy efforts, JA Camps, Biosimilars and the 24/7 Helpline. Janssen has also earned the Arthritis Foundation’s Ease of Use Certification for their prescription medical device. To learn more about Janssen, please visit www.janssen.com.


Novartis supports the Arthritis Foundation in a number of ways, including supporting programs such as the JA Family Summit, Jingle Bell Run, Science Consortium and the Arthritis Healthcare Forum.  To learn more about Novartis, please visit www.novartis.com.


Pacira is leading a new era in pain management by delivering innovative, non-opioid therapies that transform patients' lives. These advanced treatments effectively address a wide range of pain needs, including chronic, postsurgical, and musculoskeletal pain. As part of this commitment, Pacira also supports individuals with arthritis by providing valuable resources and a strong patient community. Pacira and the Arthritis Foundation are also committed to the implementation of the NOPAIN Act, which is a legislative proposal aimed at addressing the opioid crisis in the United States by promoting the use of non-opioid pain management alternatives and improving access to care for people with chronic pain. To learn more about Pacira, visit https://www.pacira.com/.